BIO vs KMI · rev $651.0M vs P/E 24, rev $9.30B
BIO (BIO) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
BIO currently screens at market cap $0. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the BIO and KMI stock pages for the full models.
Not investment advice.